New device could help heart failure patients avoid repeat hospital stays

NCT ID NCT07173426

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This trial tests whether a quick, painless electrical test called bioimpedance analysis (BIA) can help doctors better manage fluid levels in patients hospitalized with worsening heart failure. 255 participants will be randomly assigned to receive either BIA-guided treatment or standard care. The goal is to see if BIA reduces the need for extra diuretics or rehospitalization within 90 days after discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bioimpedance analysis device
What this could lead to
If it works, this could provide a simple bedside tool to guide diuretic treatment, potentially reducing hospital readmissions and improving fluid management for heart failure patients.
What could go wrong
This is a relatively small, early-stage trial (255 participants) testing a device, not a drug. The benefit may be modest, and results may not apply to all heart failure patients, especially those with severe illness or kidney problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Basildon University Hospital

    RECRUITING

    Basildon, Essex, SS16 5NL, United Kingdom

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.